Trial Profile
A study investigating effects of deposits of amyloid ß (Aß) on florbetaben F18 PET scan in patients with alzheimer's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs Florbetaben F18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 19 Oct 2015 New trial record